rs6871626

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000641150.1(IL12B-AS1):​n.533-16740C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.288 in 151,938 control chromosomes in the GnomAD database, including 6,570 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6570 hom., cov: 31)

Consequence

IL12B-AS1
ENST00000641150.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.285

Publications

82 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000641150.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000641150.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12B-AS1
ENST00000635333.1
TSL:5
n.327+7207C>A
intron
N/A
IL12B-AS1
ENST00000641150.1
n.533-16740C>A
intron
N/A
IL12B-AS1
ENST00000648969.1
n.54-16740C>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.288
AC:
43724
AN:
151820
Hom.:
6566
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.191
Gnomad AMI
AF:
0.348
Gnomad AMR
AF:
0.274
Gnomad ASJ
AF:
0.233
Gnomad EAS
AF:
0.344
Gnomad SAS
AF:
0.380
Gnomad FIN
AF:
0.291
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.340
Gnomad OTH
AF:
0.300
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.288
AC:
43744
AN:
151938
Hom.:
6570
Cov.:
31
AF XY:
0.286
AC XY:
21259
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.191
AC:
7929
AN:
41438
American (AMR)
AF:
0.274
AC:
4185
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.233
AC:
806
AN:
3466
East Asian (EAS)
AF:
0.345
AC:
1771
AN:
5140
South Asian (SAS)
AF:
0.379
AC:
1825
AN:
4814
European-Finnish (FIN)
AF:
0.291
AC:
3067
AN:
10542
Middle Eastern (MID)
AF:
0.340
AC:
100
AN:
294
European-Non Finnish (NFE)
AF:
0.340
AC:
23114
AN:
67950
Other (OTH)
AF:
0.299
AC:
631
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1528
3057
4585
6114
7642
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
468
936
1404
1872
2340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.323
Hom.:
24776
Bravo
AF:
0.282
Asia WGS
AF:
0.361
AC:
1255
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.0
DANN
Benign
0.49
PhyloP100
-0.28

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs6871626;
hg19: chr5-158826792;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.